Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2025-12-28 @ 11:54 AM
Study NCT ID:
NCT03833661
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2019-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Sponsor:
EMD Serono Research & Development Institute, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-06
First Submit QC Date:
None
Study First Post Date:
2019-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-29
Results First Submit QC Date:
None
Results First Post Date:
2022-01-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-24
Last Update Post Date:
2023-10-25
Last Update Post Date Type:
ACTUAL